Literature DB >> 22265533

Development of an analytical method using reversed-phase HPLC-PDA for a semipurified extract of Paullinia cupana var. sorbilis (guaraná).

Traudi Klein1, Renata Longhini, João Carlos Palazzo de Mello.   

Abstract

The Neotropical plant 'guaraná' has been widely used in medicine, cosmetics, and industry because of its versatile biological activities. These effects are mainly attributed to the presence of polyphenols. An efficient, precise, and reliable method was developed for quantification of the polyphenols catechin and epicatechin in guaraná extract solution, using HPLC-PDA detection. The ideal conditions for the analysis of a semipurified extract of guaraná (EPA), using solutions of 0.05% TFA-water (phase A) and 0.05% TFA in acetonitrile:methanol (75:25, vv(-1)) (phase B) as mobile phases were established. Gradient reversed-phase chromatography was performed using a guard cartridge (C18, 4.6mm×20mm, 4μm) and column (C18, 250mm×4.6mm, 4μm), flow of 0.5mLmin(-1) and detection at 280nm. The main validation parameters of the method were also determined. The method was linear over a range of 18.75-300μgmL(-1) for catechin and epicatechin, with detection limits of 0.70 and 0.88μgmL(-1) and quantification limits of 2.13 and 2.67μgmL(-1), respectively. The method also showed consistent mean recoveries of 91.3±3.8%, 2.14 RSD and 93.4±3.1, 2.74 RSD of catechin and epicatechin respectively. The relative standard deviations were relatively low: intra-day (0.72% and 0.66% for catechin and epicatechin, respectively) and inter-day (0.93% and 0.75% for catechin and epicatechin, respectively). The semipurified extract showed catechin, epicatechin, and caffeine contents of 180.75, 278.87, and 300.87μgmg(-1), respectively. The results demonstrated the efficiency, precision, accuracy, and robustness of the proposed method. The solutions remained stable for a sufficient time (one week) to complete the analytical process.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22265533     DOI: 10.1016/j.talanta.2011.11.023

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  4 in total

1.  Evaluation of Antibacterial, Antineoplastic, and Immunomodulatory Activity of Paullinia cupana Seeds Crude Extract and Ethyl-Acetate Fraction.

Authors:  Lidiane Vasconcelos do Nascimento Carvalho; Marina Ferraz Cordeiro; Thiago Ubiratan Lins E Lins; Maria Clara Pinheiro Duarte Sampaio; Gabriela Souto Vieira de Mello; Valécia de Cassia Mendonça da Costa; Leila Larisa Medeiros Marques; Traudi Klein; João Carlos Palazzo de Mello; Isabella Macário Ferro Cavalcanti; Ivan da Rocha Pitta; Maira Galdino da Rocha Pitta; Moacyr Jesus Barreto de Melo Rêgo
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-07       Impact factor: 2.629

2.  In vitro evaluation of the protective effects of plant extracts against amyloid-beta peptide-induced toxicity in human neuroblastoma SH-SY5Y cells.

Authors:  Ana Luiza Sereia; Marcelo Tempesta de Oliveira; Adrivanio Baranoski; Leila Larisa Medeiros Marques; Fabianne Martins Ribeiro; Raquel Garcia Isolani; Daniela Cristina de Medeiros; Danielly Chierrito; Danielle Lazarin-Bidóia; Acácio Antonio Ferreira Zielinski; Cláudio Roberto Novello; Celso Vataru Nakamura; Mário Sérgio Mantovani; João Carlos Palazzo de Mello
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

3.  Herb-Drug Interaction of Paullinia cupana (Guarana) Seed Extract on the Pharmacokinetics of Amiodarone in Rats.

Authors:  Márcio Rodrigues; Gilberto Alves; Nulita Lourenço; Amílcar Falcão
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-05       Impact factor: 2.629

4.  Development and Validation of a HPLC-UV Method for the Evaluation of Ellagic Acid in Liquid Extracts of Eugenia uniflora L. (Myrtaceae) Leaves and Its Ultrasound-Assisted Extraction Optimization.

Authors:  Paulo Isaac Dias Assunção; Edemilson Cardoso da Conceição; Leonardo Luiz Borges; Joelma Abadia Marciano de Paula
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-06       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.